Study LeadF. Hoffmann-La Roche, Ltd., Basel, SwitzerlandOslo, Oslo, Norway
PB0203 - NON-INTERVENTIONAL study on health-related quality of life, physical activity and bleeds in severe non-inhibitor hemophilia A patients with a bleeding phenotype on FVIII prophylaxis in the Nordics
Sunday, June 23, 202413:45 – 14:45 ICT